Sign Up to like & get
recommendations!
0
Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-5833
Abstract: There are remarkable advances in immunotherapy which have transformed solid tumor therapy outcomes for many patients. Immunotherapy rationales include checkpoint inhibitor monoclonal antibodies (CIMA) or chimeric antigen receptor T cell therapy that have become primary…
read more here.
Keywords:
anergy targeting;
immune anergy;
tumor;
overcoming immune ... See more keywords